.jpg)
BIOMARKERS FOR DIAGNOSIS, PROGNOSIS, PREVENTION, IMPROVEMENT OR RELIEF IN THE TREATMENT OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Patent number:
WO22129668
No items found.
The present invention describes the use of lncRNA AL133346.1, optionally combined with mRNAs, for the diagnosis, prognosis, prevention, improvement, relief or treatment of childhood B-cell acute lymphoblastic leukemia, and methods, kits and devices based on said use.
Countries:
Spain
Regions:
Andalusia
Centers:
UNIVERSIDAD DE GRANADA
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 2 – technology concept formulated
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
Use of lncRNA and mRNA as diagnostic biomarkers for pediatric B-ALL. Support in the therapeutic strategy of patients with pediatric B-ALL. No specific equipment is necessary. Simple method.
Comments